PeterJCasterellaMD

PubMed

• 10 citations
  One-year results of the ICON (ionic versus non-ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study
  Gennaro Giustino, Usman Baber, Ioannis Mastoris, Georgios J. Vlachojannis, Jennifer Yu, Paul S. Teirstein, William E. Downey, Wayne B. Batchelor, Peter J. Casterella, ...> ;Catheterization and Cardiovascular Interventions. 2016 Mar 1
• 590 citations
  Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
  Matthew T. Roe, Paul W. Armstrong, Keith A.A. Fox, Harvey D. White, Dorairaj Prabhakaran, Shaun G. Goodman, Jan H. Cornel, Deepak L. Bhatt, Peter Clemmensen, Felipe Ma...> ;The New England Journal of Medicine. 2012 Oct 3
• 55 citations
  Ionic Low-Osmolar Versus Nonionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients: The ICON (Ionic vers...
  Roxana Mehran, Eugenia Nikolsky, Ajay J. Kirtane, Adriano Caixeta, S. Chiu Wong, Paul S. Teirstein, William E. Downey, Wayne B. Batchelor, Peter J. Casterella, Young-H...> ;JACC. Cardiovascular Interventions. 2009 May 1
• 19 citations
  Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic the...
  Peter J. Casterella, James E. Tcheng> ;American Heart Journal. 2008 May 1
• 3 citations
  Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention.
  Peter J. Casterella, Revenaugh, Burke Jl, Robert R. Pearson, Tami L Bair, Heidi Thomas May, Benjamin D. Horne, Jeffrey L. Anderson, Joseph B. Muhlestein> ;The Journal of Invasive Cardiology. 2008 Mar 1
• 76 citations
  Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Usi...
  Deepak L. Bhatt, Benjamin I Lee, Peter J. Casterella, Mark Pulsipher, Matthew Rogers, Marc Cohen, Victor E. Corrigan, Thomas J. Ryan, Jeffrey A. Breall, Jeffrey W. Mos...> ;Journal of the American College of Cardiology. 2003 Jan 1
• 4 citations
  The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable
  Peter J. Casterella, Dean J. Kereiakes, Steven R. Steinhubl, Russell E. Raymond, Kandice Kottke-Marchant, Karen Patel, Michelle Mueller, Monique Rosenthal, David J. Mo...> ;Catheterization and Cardiovascular Interventions. 2001 Dec 1
• 251 citations
  Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-...
  Steven R. Steinhubl, J. David Talley, Gregory A. Braden, James E. Tcheng, Peter J. Casterella, David J. Moliterno, Frank I. Navetta, Peter B. Berger, Jeffrey J. Popma,...> ;Circulation. 2001 May 29
• 17 citations
  Restenosis after Angioplasty.
  Mehran Moussavian, Peter J. Casterella, Paul S. Teirstein> ;Current Treatment Options in Cardiovascular Medicine. 2001 Apr 1
• 48 citations
  Prevention of coronary restenosis.
  Peter J. Casterella, Paul S. Teirstein> ;Cardiology in Review. 1999 Jul 1
• 4 citations
  Restenosis: an overview.
  P J Casterella> ;Frontiers of Radiation Therapy and Oncology. 2001 Jan 1
• Prevalence of HIV antibody among a group of paraphilic sex offenders.
  Di Giovanni, C., Berlin, F., Casterella, P., Redfield, R. R., Hiken, M., Falck, A., Malin, H. M., Gagliano, S., Schaerf, F., Roberts, C.> ;J Acquir Immune Defic Syndr. 1991
• Join now to see all